IL210404A0
(en )
2011-03-31
Combination of a c- met antagonist and an aminoheteroaryl compound for the treatment of cancer
HK1224200A1
(en )
2017-08-18
Medicament for the treatment of cancer of the pancreas
PL2303021T3
(en )
2019-10-31
Compounds for the treatment of cancer
HK1165294A1
(en )
2012-10-05
Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect
ZA200807934B
(en )
2009-11-25
Cancer treatments
IL196470A
(en )
2016-07-31
Antagonist antibody for the treatment of cancer
EP2119627A4
(en )
2013-05-29
Noise reduction device
ZA201201984B
(en )
2013-05-29
Treating notch1- antagonist- resistant cancer (s)using notch3 antagonists
TWI349990B
(en )
2011-10-01
Shielded via
HK1143157A1
(en )
2010-12-24
4-pyridinone compounds and their use for cancer 4-
GB0716026D0
(en )
2007-09-26
An inhalable medicament
IL205137A0
(en )
2010-11-30
5-cyanothienopyridines for the treatment of tumours
EP2139469A4
(en )
2011-09-07
Cobalamin taxane bioconjugates
IL206189A0
(en )
2010-12-30
Compound for use in the treatment of cancer
HK1254607A1
(en )
2019-07-26
Organoarsenic compound for the treatment of cancer
PL2331092T3
(en )
2014-08-29
Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer
EP2222689A4
(en )
2011-11-30
Compounds for therapy and diagnosis
GB0818965D0
(en )
2008-11-26
Dental shield
GB0707556D0
(en )
2007-05-30
Treatment for cancer
ZA201100274B
(en )
2011-09-28
Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer
GB0809046D0
(en )
2008-06-25
Cancer treatment
GB0617299D0
(en )
2006-10-11
Compounds for imaging and therapy
GB0710871D0
(en )
2007-07-18
Cancer treatment
GB0814469D0
(en )
2008-09-10
Treatment for tumours
GB0604114D0
(en )
2006-04-12
Combinations for the treatment of cancer